Octreotide is a man-made protein that shares similar properties to the natural hormone, somatostatin. It works as a treatment for severe diarrhea and other symptoms associated with gastrointestinal disorders caused by vasoactive intestinal peptide tumors (VIPomas) or metastatic carcinoid tumors. As an octapeptide, Octreotide operates by inhibiting the activity of certain hormones including insulin, glucagon, and growth hormone in the gastrointestinal system. It is often used to decrease the production of these hormones when produced in excess.

Parent: Octreotide
Parent: Octreotide
Octreotide’s production process can result in various impurities, the quantities of which are stringently regulated to ensure that they are kept within safe and permissible limits. These impurities may include synthesis derivatives, residual solvents, inorganic reagents, heavy metals and reagents, and degradation products formed during storage. Quality control of these impurities is vital for the safety, efficacy, and stability of the Octreotide drug product.
Octreotide is notably utilized for the treatment of gastrointestinal bleeding. The medication aids in decreasing bleeding by reducing blood flow to the abdomen, thereby assisting in the treatment of variceal bleeding in the stomach or esophagus.
Yes, octreotide is a synthetic form of the naturally occurring hormone, somatostatin. It copies many of the effects of natural somatostatin including the inhibition of certain hormones to regulate various body functions.
No, Octreotide is not an insulin, but it influences the production of insulin in the body. The medication operates by inhibiting the secretion of insulin and other hormones to control their production when they are in excess.
Liver patients, notably those with cirrhosis, get octreotide as a treatment for variceal bleeding which is a critical complication of their condition. Octreotide aids in reducing blood flow to the area, aiding in controlling and preventing the bleeding.